News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
98,709 Results
Type
Article (2301)
Company Profile (30)
Press Release (96378)
Multimedia
Podcasts (2)
Webinars (1)
Section
Business (37936)
Career Advice (58)
Deals (5887)
Drug Delivery (7)
Drug Development (9597)
Employer Resources (7)
FDA (4474)
Job Trends (2208)
News (56990)
Policy (4030)
Tag
Academia (201)
Accelerated approval (10)
Adcomms (1)
Allergies (14)
Alliances (4033)
ALS (11)
Alzheimer's disease (240)
Antibody-drug conjugate (ADC) (40)
Approvals (4569)
Artificial intelligence (72)
Autoimmune disease (11)
Automation (3)
Bankruptcy (34)
Best Places to Work (2091)
Biosimilars (14)
Biotechnology (19)
Bladder cancer (40)
Brain cancer (7)
Breast cancer (137)
Cancer (809)
Cardiovascular disease (60)
Career advice (55)
Career pathing (1)
CAR-T (19)
CDC (3)
Cell therapy (69)
Cervical cancer (7)
Clinical research (9029)
Collaboration (131)
Compensation (78)
Complete response letters (1)
COVID-19 (213)
CRISPR (10)
C-suite (45)
Cystic fibrosis (9)
Data (1178)
Denatured (1)
Depression (28)
Diabetes (57)
Diagnostics (1107)
Digital health (7)
Diversity (2)
Diversity, equity & inclusion (2)
Drug discovery (28)
Drug pricing (6)
Duchenne muscular dystrophy (51)
Earnings (32904)
Editorial (6)
Employer branding (1)
Employer resources (5)
Events (12164)
Executive appointments (49)
FDA (5424)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (118)
Gene editing (14)
Generative AI (3)
Gene therapy (58)
GLP-1 (95)
Government (375)
Grass and pollen (2)
Guidances (281)
Healthcare (2838)
HIV (16)
Huntington's disease (8)
IgA nephropathy (22)
Immunology and inflammation (25)
Immuno-oncology (6)
Indications (35)
Infectious disease (252)
Inflammatory bowel disease (37)
Influenza (15)
Intellectual property (28)
Interviews (4)
IPO (4003)
IRA (2)
Job creations (230)
Job search strategy (49)
JPM (6)
Kidney cancer (5)
Labor market (9)
Layoffs (43)
Legal (670)
Liver cancer (9)
Longevity (1)
Lung cancer (120)
Lymphoma (87)
Machine learning (3)
Management (1)
Manufacturing (62)
MASH (39)
Medical device (3118)
Medtech (3134)
Mergers & acquisitions (2028)
Metabolic disorders (165)
mRNA (8)
Multiple sclerosis (33)
NASH (6)
Neurodegenerative disease (31)
Neuropsychiatric disorders (16)
Neuroscience (408)
Neurotech (1)
NextGen: Class of 2026 (677)
Non-profit (301)
Now hiring (4)
Obesity (62)
Opinion (13)
Ovarian cancer (20)
Pain (49)
Pancreatic cancer (37)
Parkinson's disease (32)
Partnered (4)
Patents (46)
Patient recruitment (44)
Peanut (4)
People (3726)
Pharmaceutical (9)
Pharmacy benefit managers (2)
Phase 1 (2164)
Phase 2 (3714)
Phase 3 (3729)
Pipeline (1849)
Policy (16)
Postmarket research (349)
Preclinical (762)
Press Release (5)
Prostate cancer (42)
Radiopharmaceuticals (33)
Rare diseases (99)
Real estate (355)
Recruiting (3)
Regulatory (3715)
Reports (12)
Research institute (278)
Resumes & cover letters (4)
Rett syndrome (8)
RNA editing (2)
RSV (18)
Schizophrenia (22)
Series A (14)
Series B (8)
Sickle cell disease (15)
Special edition (2)
Spinal muscular atrophy (21)
Sponsored (1)
Startups (237)
Stomach cancer (4)
Supply chain (8)
Tariffs (5)
The Weekly (1)
Vaccines (103)
Venture capital (10)
Weight loss (39)
Women's health (11)
Worklife (3)
Date
Today (37)
Last 7 days (230)
Last 30 days (523)
Last 365 days (5584)
2026 (753)
2025 (5712)
2024 (6677)
2023 (7294)
2022 (8877)
2021 (8884)
2020 (8134)
2019 (6227)
2018 (4946)
2017 (4618)
2016 (3580)
2015 (4918)
2014 (3321)
2013 (2617)
2012 (2752)
2011 (2817)
2010 (2802)
Location
Africa (62)
Alabama (14)
Arizona (44)
Arkansas (2)
Asia (5273)
Australia (579)
California (2183)
Canada (661)
China (125)
Colorado (124)
Connecticut (74)
Delaware (79)
Europe (12015)
Florida (319)
Georgia (90)
Idaho (4)
Illinois (142)
India (5)
Indiana (167)
Iowa (1)
Japan (100)
Kansas (18)
Kentucky (13)
Louisiana (8)
Maine (17)
Maryland (238)
Massachusetts (1249)
Michigan (55)
Minnesota (173)
Mississippi (2)
Missouri (20)
Montana (3)
Nebraska (1)
Nevada (20)
New Hampshire (19)
New Jersey (638)
New Mexico (6)
New York (661)
North Carolina (196)
North Dakota (1)
Northern California (1211)
Ohio (81)
Oklahoma (4)
Oregon (4)
Pennsylvania (524)
Rhode Island (3)
South America (96)
South Carolina (3)
Southern California (754)
Tennessee (45)
Texas (291)
United States (7580)
Utah (54)
Virginia (24)
Washington D.C. (6)
Washington State (128)
West Virginia (1)
Wisconsin (16)
98,709 Results for "51".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MAIA Biotechnology Announces $1.51 Million Private Placement
December 17, 2025
·
4 min read
Press Releases
Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement
December 8, 2025
·
10 min read
Press Releases
RFU Helix 51 Incubator Company Receives Illinois Innovation Voucher Grant Award for Cancer-Drug Development
January 7, 2026
·
1 min read
Press Releases
Biologics Manufacturing Market Size to Hit USD 162.51 Billion by 2034, Growing at an Extraordinary 17.1% CAGR
November 20, 2025
·
1 min read
Press Releases
Real-world head-to-head analysis shows 51% reduction in risk of death for patients with metastatic castration-sensitive prostate cancer treated with ERLEADA® (apalutamide) versus darolutamide without docetaxel through 24 months
February 2, 2026
·
17 min read
Press Releases
Life Science Logistics Market to Reach USD 262.51 Billion by 2034, Drives Rising Demand for Biologics and Supply Chain Advancements
October 28, 2025
·
1 min read
Press Releases
Medexus Announces US$51.0 million in New Credit Facilities and Intention to Commence Normal Course Issuer Bid, or NCIB, for its Common Shares
November 17, 2025
·
6 min read
Press Releases
Small Cell Lung Cancer Therapeutics Market to Hit $5.1 Billion by 2032, at a CAGR of 9.1%, says Coherent Market Insights
October 17, 2025
·
1 min read
Press Releases
U.S. Life Science Tools Market Size to Hit USD 156.51 Billion by 2034
June 13, 2025
·
1 min read
Drug Development
PepGen Announces First Patient Dosed in CONNECT1-EDO51 Phase 2 Clinical Trial of PGN-EDO51 for Duchenne Muscular Dystrophy Patients Amenable to Exon 51 Skipping
PepGen Inc. announced that the first patient has been dosed in its CONNECT1-EDO51 Phase 2, open-label multiple ascending dose clinical trial evaluating PGN-EDO51 for the treatment of Duchenne muscular dystrophy patients amendable to an exon 51 skipping therapy.
January 8, 2024
·
7 min read
1 of 9,871
Next
